Recursion Pharmaceuticals Inc’s stock has had a tumultuous market performance.
52-week price history of RXRX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Recursion Pharmaceuticals Inc’s current trading price is -59.30% away from its 52-week high, while its distance from the 52-week low is 32.72%. The stock’s price range during this period has fluctuated between $3.79 and $12.36. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 32.06 million for the day, which was evidently higher than the average daily volume of 24.01 million over the last three months.
Financial Performance and Market Capitalization
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -22.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.04B.
Moving average and trading volume data
RXRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
RXRX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -46.32% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -32.39%. Over the past 30 days, the price of RXRX has fallen by 10.55%. And in the last five days, it has fallen by -2.71%.
